Surface sterilisation

Healthcare Associated Infections (HAI’s), commonly also known as Hospital Acquired Infections, are a major global health care problem, resulting in the death of hundreds of thousands of people every year.

According to the U.S. Centers for Disease Control and Prevention (CDC), in the US alone drug-resistant bacteria annually infect more than 2 million people and are responsible for the deaths of over 23,000 people every year.

Some of the most dangerous superbugs such as MRSA and Clostridium Difficile regularly infect patients within the health care environment.

The World Health Organization has labeled antibiotic resistance a ‘fundamental threat to humanity’

Whilst there are several disinfection solutions that have emerged in recent years with partial success, limiting factors continue to be their effectiveness, kill rates, toxicity and cost.

PuriflOH aims to utilize the FRG technology to develop a highly effective, chemical free device that is able to rapidly and fully sanitize internal rooms and facilities. Whilst there are multiple markets that would benefit from effective surface sterilisation, a high impact focus is hospitals and medical facilities.


The device would would decontaminate both the air and the surfaces within a given environment through the rapid deployment of a powerful and highly penetrative fume, eliminating bacteria on contact with no resultant residue. The elimination of such pathogens then reduces the risk of transference between patients, staff and visitors, a root cause of the HAI infection crisis.

The sterilisation device will require only water and electricity to operate, is fully remote controlled and is operated to ensure complete safety to patients and staff. The byproducts of the system are completely benign with no chemical residue. The automated system will operate safely, quickly and powerfully with an objective of complete sanitization of typical hospital room in less than 45 minutes.